A bullish thesis on Coty Inc. argues the $5.8 billion global fragrance and beauty company is positioned for a significant re-rating. The core prestige fragrance segment continues to grow at high-single-digit rates, while the Consumer Beauty division is under strategic review for potential sale or restructuring. A former Procter and Gamble veteran has been appointed, consolidating CEO and Chairman roles and signaling aggressive cost and portfolio rationalization. Financially, the business generates over $500 million in operating cash flow with manageable near-term debt maturities. On valuation, a normalization to 8x EBITDA implies a share price near $4, and a sale of Consumer Beauty or further multiple expansion could drive $5 to $8 per share outcomes.
Coty IncBullish thesis cites potential re-rating, cost rationalization, and valuation expansion to $4-$8 per share.
Procter & Gamble Company